Cancer Discovery

@CD_AACR

Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by .

Vrijeme pridruživanja: srpanj 2018.

Tweetovi

Blokirali ste korisnika/cu @CD_AACR

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CD_AACR

  1. Prikvačeni tweet
    9. sij

    The January issue of Cancer Discovery is now online!

    Poništi
  2. prije 18 sati
    Poništi
  3. proslijedio/la je Tweet

    Advances in the Treatment of Acute Myeloid : New Drugs and New Challenges | via | , Konopleva, , , Ravandi, DiNardo, and of .

    Poništi
  4. proslijedio/la je Tweet
    prije 21 sat

    , executive editor, joins us to talk to about !

    Poništi
  5. prije 21 sat
    Poništi
  6. proslijedio/la je Tweet
    3. velj

    Very excited to share this important review in by synthesizing all the recent discoveries on CAF heterogeneity in !

    Poništi
  7. proslijedio/la je Tweet
    4. velj

    Today is . The AACR is the authoritative source of information about advances in the causes, diagnosis, treatment and prevention of cancer.

    Poništi
  8. 4. velj
    Poništi
  9. proslijedio/la je Tweet
    3. velj

    State unlocked: Michigan - excited for my visit to !

    Poništi
  10. proslijedio/la je Tweet
    3. velj

    Pleasure to review CAF heterogeneity in . Much more to learn, and exciting discoveries on the horizon (h/t and the Twitter-free PDAC fibromaniacs)

    Poništi
  11. 3. velj

    From the January issue: The first-in-human of -pathway blockade for cancer

    Poništi
  12. 3. velj

    From the January issue: The inhibitor MRTX849 provides insight into therapeutic susceptibility of -mutant cancers in mouse models and patients.

    Poništi
  13. 3. velj

    Associate Editor is at - be sure to say hello!

    Poništi
  14. proslijedio/la je Tweet

    Pediatric cancer survivorship portal released. “We want to make this data accessible to as many types of scientific researchers & clinicians as possible." -Dr. Alex Gout, lead scientist of the St. Jude Cloud project.

    Poništi
  15. 31. sij

    Cancer Discovery News : A curated list of recent breaking news.

    Poništi
  16. 31. sij
    Poništi
  17. 31. sij

    From the January issue: PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in

    Poništi
  18. 30. sij

    Just published! Impaired death-receptor signaling in causes antigen-independent resistance by inducing CAR-T cell dysfunction

    Poništi
  19. proslijedio/la je Tweet
    30. sij

    In this study, we discovered that impaired death receptor signaling in leukemia causes antigen-independent resistance to CAR T cells by causing T cell dysfunction.

    Poništi
  20. proslijedio/la je Tweet
    30. sij

    So excited to share our paper from my time with out now in ! Ton of collaborative work: thanks to , Saar Gill, , and others . Check it out!

    Poništi
  21. 30. sij

    From the January issue: PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·